SCA
STALEY CAPITAL ADVISERS Portfolio holdings
AUM
$2.35B
1-Year Est. Return
16.46%
1 Year Est. Return
+16.46%
AUM
$2.35B
AUM Growth
+$141M
(+6.4%)
Holding
196
Top Buys
| 1 | +$8.53M | |
| 2 | +$7.03M | |
| 3 | +$4.37M | |
| 4 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$2.57M |
| 5 |
DuPont de Nemours
DD
|
+$2.57M |
Top Sells
| 1 | +$6.79M | |
| 2 | +$5.06M | |
| 3 | +$4.39M | |
| 4 |
FedEx
FDX
|
+$3.84M |
| 5 |
Pfizer
PFE
|
+$2.01M |
Sector Composition
| 1 | Technology | 23.48% |
| 2 | Financials | 12.1% |
| 3 | Communication Services | 7.7% |
| 4 | Consumer Discretionary | 7.56% |
| 5 | Materials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Planet Labs
PL
$4.19B
| $183K | 0.01% |
30,000
|
|
||
177
VanEck Preferred Securities ex Financials ETF
PFXF
$1.96B
| $171K | 0.01% |
10,000
|
|
||
|
PMO
178
Putnam Municipal Opportunities Trust
PMO
$291M
| $124K | 0.01% |
12,500
|
|
||
179
Nuveen Arizona Quality Municipal Income Fund
NAZ
$139M
| $117K | 0.01% |
10,000
|
|
||
180
Eos Energy Enterprises
EOSE
$4.48B
| $102K | ﹤0.01% |
20,000
|
|
||
181
Phathom Pharmaceuticals
PHAT
$960M
| $95.9K | ﹤0.01% |
10,000
|
|
||
182
VYNE Therapeutics
VYNE
$9.51M
| $84.9K | ﹤0.01% |
51,472
|
|
||
183
Ondas Holdings
ONDS
$2.6B
| $43.2K | ﹤0.01% |
22,500
|
|
||
184
Anixa Biosciences
ANIX
$136M
| $33K | ﹤0.01% |
10,000
|
|
||
185
Apollo Global Management
APO
$71.5B
| – | – |
-6,300
|
|
||
186
Blackstone
BX
$121B
| – | – |
-6,225
|
|
||
187
Carlyle Group
CG
$21.2B
| – | – |
-18,650
|
|
||
188
SLB Limited
SLB
$53.5B
| – | – |
-5,897
|
|
||
|
QVCGA
189
QVC Group Inc Series A
QVCGA
$92M
| – | – |
-20,000
|
|